Cittadine Andrew's Form 4 filing
Monopar Therapeutics (MNPR) · filed Jun 17, 2024
- Accession no.
- 0001437749-24-020547
- Filed
- Jun 17, 2024
- Trade date
- Jun 13-17, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $32.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cittadine AndrewCIK 0001863624 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | Common Stock | PPurchaseAcquired | +12,000 | $0.91 | +$10,920 | 129,624 | Direct | |
| Jun 14, 2024 | Common Stock | PPurchaseAcquired | +12,000 | $0.93 | +$11,160 | 141,624 | Direct | |
| Jun 17, 2024 | Common Stock | PPurchaseAcquired | +12,000 | $0.90 | +$10,800 | 153,624 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.